Search

Displaying results 7361 - 7370 of 10000 in total
  1. Drug

    Triapine

    go.drugbank.com/drugs/DB11940
    Investigational

    Triapine has been used in trials studying the treatment of Leukemia, Lung Cancer, Kidney Cancer, Prostate Cancer, and Pancreatic Cancer, among others.

    Synonyms: 3-Aminopyridine-2-carboxaldehyde thiosemicarbazoneCategories: Heterocyclic Compounds, 1-Ring
  2. Drug

    Teneligliptin

    go.drugbank.com/drugs/DB11950
    Investigational

    Teneligliptin has been investigated for the treatment of Type 2 Diabetes Mellitus.

    Categories: Heterocyclic Compounds, 1-Ring
  3. Drug

    Idalopirdine

    go.drugbank.com/drugs/DB11957
    Investigational

    Idalopirdine has been used in trials studying the treatment of Cognition, Schizophrenia, and Alzheimer's Disease.

    Categories: Heterocyclic Compounds, 2-Ring
  4. Drug

    AZD-1236

    go.drugbank.com/drugs/DB11961
    Investigational

    AZD1236 has been used in trials studying the basic science and treatment of Cystic Fibrosis and Chronic Obstructive Pulmonary Disease.

    Categories: Heterocyclic Compounds, 1-Ring
  5. Drug

    SJG-136

    go.drugbank.com/drugs/DB11965
    Investigational

    SJG-136 has been used in trials studying the treatment of Recurrent Fallopian Tube Cancer, Secondary Acute Myeloid Leukemia, de Novo Myelodysplastic Syndromes, Recurrent Ovarian Epithelial Cancer, and

    Categories: P-glycoprotein substrates, Heterocyclic Compounds, 1-Ring
  6. Drug

    BMS-986094

    go.drugbank.com/drugs/DB11966
    Investigational

    INX-08189 has been used in trials studying the treatment of Hepatitis C, HCV (Genotype 1), and Hepatitis C Virus.

    Categories: Heterocyclic Compounds, 2-Ring
  7. Drug

    Binimetinib

    go.drugbank.com/drugs/DB11967
    ApprovedInvestigational

    Binimetinib, also known as _Mektovi_, is a potent and selective oral mitogen-activated protein kinase 1/2 (MEK 1/2) inhibitor which is combined with [Encorafenib].

    Categories: P-glycoprotein substrates with a Narrow Therapeutic Index, Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic IndexProducts: MEKTOVI® 15 MG TABLETAS RECUBIERTAS
  8. Drug

    Uprosertib

    go.drugbank.com/drugs/DB11969
    Investigational

    Uprosertib has been used in trials studying the treatment of Cancer, Melanoma, Solid Tumours, Cervical Cancer, and HER2/Neu Negative, among others.

    Categories: Heterocyclic Compounds, 1-Ring
  9. Drug

    Vilaprisan

    go.drugbank.com/drugs/DB11971
    Investigational

    Vilaprisan has been used in trials studying the treatment of Leiomyoma and Clinical Trial, Phase I.

  10. Drug

    Golvatinib

    go.drugbank.com/drugs/DB11977
    Investigational

    Golvatinib has been investigated for the treatment of Platinum-Resistant Squamous Cell Carcinoma of the Head and Neck.

    Categories: Heterocyclic Compounds, 1-Ring, Vascular Endothelial Growth Factor Receptor-2, antagonists & inhibitors